Central Drugs Standard Control Organization (CDSCO): News

11 Oct 2023


Uzbekistan cough syrup deaths: India allows company to reopen factory

The Uttar Pradesh government has allowed Marion Biotech, which manufactured the cough syrup responsible for the deaths of 65 kids in Uzbekistan last year, to restart most production, Reuters reported.

Toxic levels of chemicals found in Indian-manufactured syrups again: Report

The Central Drugs Standard Control Organization (CDSCO) has claimed that the Gujarat Food and Drug Control Administration (FDCA) found toxic levels of ethylene glycol and diethylene glycol in batches of cough and allergic rhinitis syrups manufactured by Norris Medicines.

28 Jun 2023


Indian company used toxic industrial chemical in syrup: Report

The India-made cough syrups linked to at least 19 deaths in Uzbekistan contained a toxic industrial-grade ingredient rather than the legitimate pharmaceutical version, Reuters reported.

18 Jan 2023

Union Health Ministry

Centre refutes reports on side-effects of COVID-19 vaccines

The Union Health Ministry on Tuesday rejected reports claiming that the Central Drugs Standard Control Organization (CDSCO) and Indian Council of Medical Research (ICMR) had admitted to numerous side effects of COVID-19 vaccines.

23 Dec 2022


COVID-19: Centre approves Bharat Biotech's nasal vaccine as booster dose

Union Health Minister Mansukh Mandaviya informed on Friday that the Centre has approved Bharat Biotech's nasal vaccine to be used as a heterologous booster.

Haryana government halts cough syrup production linked to Gambia deaths

The Haryana government suspended cough syrup production at a Maiden Pharmaceuticals facility on Wednesday, a week after the World Health Organization (WHO) warned that the drug may be related to the deaths of scores of children in the Gambia.

06 Oct 2022


66 Gambia deaths: Centre probes Indian company's 4 cough syrups

After the death of 66 children in the Gambia, the World Health Organization (WHO) issued an alert against using four fever, cold, and cough syrups manufactured by Maiden Pharmaceuticals Limited — an Indian pharmaceuticals company based in Haryana.

Expert panel recommends emergency use authorization for Zydus's three-dose vaccine

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting an emergency use authorization (EUA) to ZyCoV-D, the three-dose COVID-19 vaccine developed by Zydus Cadila, on Friday.

02 Aug 2021

Johnson & Johnson

J&J withdraws vaccine approval request in India, CDSCO says

Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.

Government expert panel recommends conducting trials on mixing Covishield, COVAXIN

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has given its go-ahead for conducting clinical trials involving the mixing and matching of Covishield and COVAXIN vaccine doses.

Expert panel says no to Covovax's children trials in India

A Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has denied permission to Pune-based Serum Institute of India (SII) for conducting clinical trials of its second COVID-19 vaccine, Covovax, in children.

12 May 2021


COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel

In a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended Hyderabad-based Bharat Biotech's COVID-19 vaccine COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.

15 Apr 2021


Foreign COVID-19 vaccines: Decision on EUA applications within three days

India's drug regulator will make a decision on applications seeking approval for restricted emergency use of foreign-produced vaccines within three working days from the date of submission, the government said on Thursday.

Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial

An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.

03 Jan 2021

Union Health Ministry

Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.

01 Jan 2021


India set to start COVID-19 vaccination; panel approves Oxford vaccine

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

31 Dec 2020


UK's approval to Oxford-AstraZeneca vaccine paves way for India

The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.

02 Dec 2020


Trial will continue: Centre on SII vaccine's "adverse reaction" claims

With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.

08 Oct 2020

Russia News

India rejects large scale trial of Russia's COVID-19 vaccine

India's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.

16 Sep 2020

Russia News

Dr. Reddy's bringing coronavirus vaccine to India by 2020-end

In a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.

12 Aug 2020


Coronavirus: How soon could Russian vaccine be available in India?

On Tuesday, Russia announced what it claims is the first COVID-19 vaccine, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow.

Remdesivir reportedly approved for COVID-19 treatment in India

Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.

24 Mar 2020


#GoodNews: Pune's Mylab approved to make COVID-19 test kits

In a major development, Pune-based molecular diagnostics company Mylab Discovery Solutions has been given the go-ahead to develop testing kits for the novel coronavirus disease (COVID-19).

SC seeks Center's response on faulty hip implants by J&J

The Supreme Court yesterday sought the Center's response on a plea alleging that "faulty" and "deadly" hip implants, made by US-based pharma major Johnson & Johnson (J&J), have been fitted into the bodies of 14,525 Indian patients, termed as "medical negligence" by an expert committee.

07 Sep 2018


Health Ministry to rename drug regulator CDSCO; invites suggestions

The Union Health Ministry has invited suggestions for renaming the country's drug regulator CDSCO in line with its expanded roles.

03 Jun 2018


Government plans to make companies responsible for drug regulation violations

To ensure the quality of drugs, Health Ministry is planning to make companies, which market and promote medicines, responsible for any violation of drug regulations like manufacturers.

Health Ministry bans sale of 14 steroid-creams sans doctor's prescription

Health Ministry has banned over-the-counter (OTC) sale of 14 steroid-based creams and ointments by bringing them under the Schedule H of the Drugs and Cosmetics Rules, 1945.

19 Sep 2017

Climate Change

Bengaluru Lake Frothing: Centre seeks CPCB's response over phosphorus pollution

Bengaluru's Bellandur Lake frothing has turned the Centre's attention to high phosphorus content in laundry detergents, bars, and industrial cleaners.